On February 10, 2025, the Group confirmed advanced discussions about a potential acquisition of SpringWorks Therapeutics ( SWTX ), Inc., USA. At the time of the preparation of the Consolidated ...
Stocktwits on MSN4d
SpringWorks Therapeutics Leads Biotech Pack In Weekly Retail Follower Surge: What's Fueling Interest?SpringWorks Therapeutics (SWTX) saw the biggest retail follower increase among biotech stocks last week on Stocktwits, even ...
Ahead of Merck KGaA’s earnings announcement Thursday, investors were mostly looking forward to any comments about its ...
SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...
We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are ...
Stamford-based SpringWorks Therapeutics, a commercial-stage biotech company developing treatments for rare diseases and cancer, is in “advanced talks” to be acquired by Germany’s Merck ...
Barclays analyst Peter Lawson says SpringWorks Therapeutics (SWTX) this morning cancelled from the firm’s conference next week, following ...
Merck KGaA reaffirmed its strong performance ... but provided little additional information on ongoing acquisition talks with SpringWorks Therapeutics. Speculation surrounding a potential ...
On Monday, Germany-based Merck KGaA (OTC:MKGAF) (OTC:MKKGY) reacted to press reports and confirmed advanced discussions with SpringWorks Therapeutics Inc (NASDAQ:SWTX), which has a market ...
A potential acquisition of SpringWorks Therapeutics by Merck KGaA could bring significant benefits to both companies and potentially create substantial value for shareholders: 1. Enhanced resources: ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback